eIF6 Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF6 monoclonal antibodies for research focused on understanding eIF6 in cellular processes. eIF6 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF6, or eukaryotic translation initiation factor 6, plays a critical role in the initiation of protein synthesis by preventing the premature association of ribosomal subunits. eIF6 is essential for maintaining the integrity of the translation machinery and influences cell growth and proliferation. Research has shown that abnormal eIF6 activity is linked to various diseases, including cancer. Understanding eIF6 function and regulation continues to be an active area of investigation in molecular biology and disease research. Scientists can explore eIF6's involvement in both normal cellular processes and pathological conditions using specific detection methods. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enabling diverse experimental approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of eIF6's role in health and disease.